Simplify Logo

Full-Time

Senior Scientist

Computational Biology

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Healthcare
Biotechnology

Senior

Cambridge, MA, USA

Category
Computational Biology
Biology & Biotech
Required Skills
Python
Git
AWS
Requirements
  • Ph.D. in computational biology, statistics, bioinformatics, or a related field.
  • 5+ years of experience applying quantitative approaches to solve biological problems.
  • Proficiency in programming with Python and working with cloud platforms (AWS preferred).
  • Energetic self-starter with the ability to work effectively in a startup environment.
  • Exemplary analytical skills and ability to synthesize & communicate complex information rapidly and effectively.
Responsibilities
  • Develop and validate preclinical target discovery models leveraging multimodal data.
  • Analyze and interpret single cell sequencing data.
  • Contribute to a cooperative software development environment through Git usage, engagement in code reviews, and individual development of reliable code.
  • Contribute to experimental design and product development decision-making.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.